Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1No longer available 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Neoplasms 2Urogenital Neoplasms 1Prostatic Neoplasms 1Osteosarcoma 1Neuroblastoma 1Neoplasm Metastasis 1Genital Neoplasms, Male 1Breast Neoplasms, Male 1Breast Neoplasms 1

Interventions

valrubicin 1palbociclib 1ixabepilone 1ferumoxtran-10 1atezolizumab 1Suspensions 1Sunitinib 1Standard of Care 1Powders 1Paclitaxel 1National Cancer Institute (U.S.) 1Mitomycin 1Magnetic Resonance Spectroscopy 1Fatty Acids, Omega-3 1Drug Therapy 1BAY 86-7548 1Atorvastatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Urogenital Neoplasms × Suspensions × Clear all
NCT04221828 2022-03-29

Trial of NanoPac Focal Therapy for Prostate Cancer

NanOlogy, LLC

Phase 2 Terminated
1 enrolled 5 charts
Genitourinary

Genital Neoplasms, Male, Prostatic Neoplasms, Urogenital Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡